Hiromi Yoshikawa

Part of Otsuka Holdings Co., Ltd., Otsuka Pharmaceutical Development & Commercialization, Inc. is a healthcare company that was founded in 2007. The private company is based in Princeton, NJ. The company is driven by their purpose and defined by their beliefs.

Diatranz Otsuka Ltd. manufactures pharmaceutical products. Its product, DIABECELL, is used to treat type1 diabetes. The company was founded on November 11, 2011 and is headquartered in Auckland, New Zealand.

Otsuka America Pharmaceutical, Inc. manufactures and supplies pharmaceutical products. It develops drugs for neuroscience, cardiovascular, and gastrointestinal treatments. The company was founded in 1989 and is headquartered in Rockville, MD.

Otsuka America, Inc. operates as a holding company for Otsuka America Pharmaceutical. Its primary objective is to bring products to the U.S. market developed by Otsuka America Pharmaceutical's Japanese parent company, Otsuka Pharmaceutical Co., Ltd. Those products center on treating neurological and cardiovascular diseases. The company was founded in 1989 and is headquartered in San Francisco, CA.

Otsuka Pharmaceutical Co. Ltd. engages in the manufacturing, distributing, exporting, and importing of pharmaceuticals, clinical testing equipment, medical device and equipment, food products, cosmetics, and other related products. Its operations are carried out through the following business divisions: Pharmaceutical Business and Nutraceutical Business. The Pharmaceutical Business division engages in the manufacture and sale of pharmaceutical products for the diagnosis and treatment of diseases. The Nutraceutical Business division provides nutritional products, cosmetics and medicines that support day-to-day health maintenance and improvement. The company was founded on August 10, 1964 and is headquartered in Tokyo, Japan.